NCT07796542

Brief Summary

Anemia is a common condition, but it often goes undiagnosed because confirming it requires a venous blood test. This study looks at whether a commercially available wrist-worn smartwatch can help identify people who may have anemia, without taking blood. The watch continuously records several types of physiological signals, including photoplethysmography (a light-based measure of blood flow), movement, heart rate, blood oxygen saturation, and heart rate variability. Researchers will use these signals to build a computer model that sorts participants into two groups: likely to have anemia, or unlikely to have anemia. About 400 adults between 18 and 80 years of age will take part at one hospital in Beijing, China. Both patients with anemia and people with normal hemoglobin levels will be included. Each participant will wear the watch and also have a standard venous blood test to measure hemoglobin, which serves as the reference for comparison. Data from the first 250 participants will be used to develop the model. Data from the next 150 participants will be used to test how well the model works in a separate group. The main question is how accurately the watch-based result matches the blood test result.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Sep 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Sep 2026Jul 2027

First Submitted

Initial submission to the registry

August 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 1, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

September 5, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2027

Last Updated

September 1, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 26, 2026

Last Update Submit

August 28, 2026

Conditions

Keywords

anemia screeningwearable devicesmartwatchphotoplethysmographynon-invasive diagnosis

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and specificity of the wearable-based deep learning model for binary anemia classification

    Agreement between the model-derived anemia versus non-anemia classification and venous hemoglobin measurement as the reference standard. Venous blood sampling is performed within 3 days before or after wearable signal acquisition.Reported as sensitivity and specificity with 95% confidence intervals in the independent validation cohort.

    Day 1

Secondary Outcomes (4)

  • Model performance stability under 24-hour continuous wear

    Day 1

  • Effect of red blood cell size classification on model estimation accuracy

    Day 1

  • Model performance stability under exercise load

    Day 1 (immediately before and after the six-minute walk test)

  • Agreement of classification results between left and right wrist placement

    Day 1

Study Arms (2)

Model development cohort

First 250 participants. Wearable multimodal physiological signals and venous hemoglobin measurement are collected in parallel and used for deep learning model development and tuning.

Independent validation cohort

Subsequent 150 participants. Data are used for independent testing of the model and to support iterative optimization.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 80 years recruited from inpatient wards and outpatient clinics at a single tertiary care hospital in Beijing, China. The population includes both participants with a hospital-confirmed diagnosis of anemia and control participants with hemoglobin within the normal reference range. Anemia is defined according to Chinese sea-level criteria: hemoglobin below 120 g/L in adult men, below 110 g/L in non-pregnant adult women, and below 100 g/L in pregnant women. For participants with anemia, a hemoglobin result obtained within the 3 days and a diagnostic report specifying anemia severity, red blood cell size classification, and anemia type are required. Enrollment targets at least 300 participants with anemia and at least 90 participants with normal hemoglobin. Participants are enrolled consecutively as they present for routine clinical care and meet eligibility criteria.

You may qualify if:

  • Age 18 to 80 years, any sex
  • Willing to participate and able to provide written informed consent
  • Able to comply with wearable device wear, venous blood sampling, and functional assessment (e.g., six-minute walk test)
  • For participants with anemia: a hemoglobin test result obtained within 3 days before or after wearable signal acquisition and a hospital diagnostic report, including anemia severity, red blood cell size classification, and anemia type. Anemia is defined according to Chinese sea-level criteria: hemoglobin below 120 g/L in adult men, below 110 g/L in non-pregnant adult women, and below 100 g/L in pregnant women
  • For control participants: hemoglobin within the normal reference range -

You may not qualify if:

  • Axillary temperature 37.3°C or higher on the day of data collection or on the preceding day
  • Acute exacerbation of a severe comorbid condition (e.g., decompensated heart failure, respiratory failure, acute infection)
  • Skin breakdown, rash, deformity, amputation, or any other condition of the upper limb precluding proper wear of the device
  • Refusal of, or intolerance to, invasive venous blood sampling
  • Concurrent participation in another interventional clinical trial -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

Related Publications (5)

  • Zhu J, Sun R, Liu H, Wang T, Cai L, Chen Z, Heng B. A Non-Invasive Hemoglobin Detection Device Based on Multispectral Photoplethysmography. Biosensors (Basel). 2023 Dec 30;14(1):0. doi: 10.3390/bios14010022.

    PMID: 38248399BACKGROUND
  • Li L, Luo R, Medina A, Rozelle S. THE PREVALENCE OF ANEMIA IN CENTRAL AND EASTERN CHINA: EVIDENCE FROM THE CHINA HEALTH AND NUTRITION SURVEY. Southeast Asian J Trop Med Public Health. 2015 Mar;46(2):306-21.

    PMID: 26513934BACKGROUND
  • Li M, Hu Y, Mao D, Wang R, Chen J, Li W, Yang X, Piao J, Yang L. Prevalence of Anemia among Chinese Rural Residents. Nutrients. 2017 Feb 24;9(3):192. doi: 10.3390/nu9030192.

    PMID: 28245576BACKGROUND
  • Liu X, Wang B, Man S, Bao H, Huang Y, Yu C, Lyu J, Wang L, Li L, Liu H. Variations in the Prevalence of Anemia of Varying Severity Among Urban Non-Pregnant Women - China, 2021. China CDC Wkly. 2024 Mar 8;6(10):175-180. doi: 10.46234/ccdcw2024.036.

    PMID: 38523814BACKGROUND
  • Shwarz M. Burden of anemia in the United States from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019. Front Public Health. 2025 Oct 3;13:1653222. doi: 10.3389/fpubh.2025.1653222. eCollection 2025.

    PMID: 41112644BACKGROUND

MeSH Terms

Conditions

Anemia

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Central Study Contacts

Jian Li, PhD

CONTACT

Miao Chen, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Hematology

Study Record Dates

First Submitted

August 26, 2026

First Posted

September 1, 2026

Study Start

September 5, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

July 15, 2027

Last Updated

September 1, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data include continuous multimodal physiological signal recordings that are potentially identifiable and cannot be adequately de-identified. Raw data will therefore not be shared with other researchers. Aggregate study results will be reported in peer-reviewed publications and in a study summary report, without any information that could identify individual participants.

Locations